<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Tushar Johri on Medium]]></title>
        <description><![CDATA[Stories by Tushar Johri on Medium]]></description>
        <link>https://medium.com/@tusharjohri?source=rss-c33b0e619aab------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*qVaOMeSRun4sYEXW.</url>
            <title>Stories by Tushar Johri on Medium</title>
            <link>https://medium.com/@tusharjohri?source=rss-c33b0e619aab------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Thu, 19 Nov 2026 02:48:11 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@tusharjohri/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Beyond the Ballot: How the 2026 US Midterms could reshape Global Markets]]></title>
            <link>https://medium.com/@tusharjohri/beyond-the-ballot-how-the-2026-us-midterms-could-reshape-global-markets-ff3bd7be5696?source=rss-c33b0e619aab------2</link>
            <guid isPermaLink="false">https://medium.com/p/ff3bd7be5696</guid>
            <category><![CDATA[ai-capital-expenditure]]></category>
            <category><![CDATA[tariffs]]></category>
            <category><![CDATA[healthcare-economics]]></category>
            <dc:creator><![CDATA[Tushar Johri]]></dc:creator>
            <pubDate>Wed, 04 Nov 2026 06:35:53 GMT</pubDate>
            <atom:updated>2026-11-04T06:35:53.493Z</atom:updated>
            <content:encoded><![CDATA[<p>The 2026 US Midterm Elections could prove to be more than a political referendum on the Trump administration. They could mark an important inflection point in how global markets price American policy, corporate investment and geopolitical risk.</p><p>The emerging Democratic sweep, with the party projected to take control of both chambers of Congress, has already triggered a reaction across financial markets. US equity futures have weakened, technology stocks have come under pressure, Treasury yields have declined and the dollar has softened.</p><p>But the more interesting story is not the immediate market reaction. It is what this political shift could mean for the next two years of economic policymaking.</p><p>Since Donald Trump returned to the White House in 2025, markets have benefited from an environment characterised by deregulation, tax incentives, aggressive trade policy and substantial corporate investment in artificial intelligence. A change in Congressional control introduces a different set of constraints, particularly around regulatory oversight, fiscal spending and corporate accountability.</p><p>The implications extend well beyond the US. Asian semiconductor supply chains, European exporters, global pharmaceutical companies and emerging-market currencies could all be affected.</p><p>There are five interconnected developments worth examining.</p><p><strong>1. The AI investment cycle: From expansion to scrutiny</strong></p><p>Perhaps the most immediate market implication is around artificial intelligence.</p><p>The AI investment cycle has become one of the most important drivers of global equity valuations. Hyperscaler spending on data centres, advanced semiconductors, cloud infrastructure and energy capacity has created an investment ecosystem extending from Silicon Valley to Taiwan, South Korea and Japan.</p><p>A Democratic-controlled Congress could introduce greater scrutiny of this ecosystem.</p><p>The debate is increasingly moving beyond the capabilities of AI models towards the broader economic and societal consequences of their deployment. Data-centre electricity consumption, water requirements, environmental impact, competition, workforce displacement and the concentration of technological power are becoming important policy considerations.</p><p><strong>This matters because the economics of AI are closely linked to the speed at which infrastructure can be deployed</strong>.</p><p>Greater regulatory oversight, investigations into technology companies and pressure on local authorities to reconsider data-centre approvals could introduce friction into an investment cycle that has largely been driven by expectations of uninterrupted expansion.</p><p>However, it is important to distinguish between regulatory scrutiny and an actual reduction in AI capital expenditure.</p><p>The larger technology companies have already committed substantial resources to infrastructure, and their competitive positioning depends heavily on continued investment.</p><p><strong>The bigger question is whether the economics of that investment begin to change.</strong></p><p>For Asian markets, this is particularly significant. Taiwan’s semiconductor ecosystem, South Korea’s memory-chip manufacturers and Japan’s semiconductor equipment suppliers are deeply integrated into the US-led AI investment cycle.</p><p>A slowdown in American data-centre expansion would <strong>not</strong> remain an American technology story. It would eventually feed into semiconductor demand, export revenues and earnings expectations across Asia.</p><p>Reuters’ November 4 market coverage highlighted precisely this concern, with technology-heavy markets in Japan, Taiwan and South Korea coming under pressure amid fears of tighter AI oversight and slower data-centre expansion.</p><p><strong>2. US Healthcare: A changing regulatory and commercial environment</strong></p><p>Healthcare could be another important area of policy divergence.</p><p>The American healthcare system sits at the intersection of government spending, private insurance, pharmaceutical innovation and consumer affordability. It is also one of the sectors most directly exposed to changes in Congressional priorities.</p><p>Greater Democratic influence could bring renewed attention to prescription drug affordability, Medicare and Medicaid funding, insurance coverage and pharmaceutical pricing.</p><p>For healthcare companies, however, the implications are unlikely to be uniform.</p><p>Pharmaceutical companies could face renewed pricing pressure, particularly around government programmes and reimbursement. Healthcare insurers could encounter greater scrutiny over coverage, premiums and the economics of government-supported insurance markets.</p><p>At the same time, healthcare services, innovative biotechnology and companies addressing significant unmet medical needs could continue to attract investment.</p><p>There is also a broader strategic consideration.</p><p>The US remains one of the most important markets for global pharmaceutical innovation. Any meaningful shift in reimbursement economics or pricing policy has implications for the commercial models of multinational pharmaceutical companies, not just domestic healthcare providers.</p><p>For investors, the distinction will be between companies whose earnings depend heavily on pricing flexibility and those with stronger innovation-led growth, differentiated portfolios and diversified revenue streams.</p><p>The key question is whether healthcare policy becomes a source of renewed cost pressure or a catalyst for a broader restructuring of the American healthcare market.</p><p><strong>3. Tariffs and trade: Why Asia remains particularly exposed</strong></p><p>Trade policy is arguably the most important transmission mechanism between Washington and the rest of the world.</p><p>The Trump administration’s tariff agenda has already influenced manufacturing decisions, sourcing strategies and international trade flows.</p><p>A Democratic-controlled Congress could bring greater scrutiny of the administration’s trade decisions, introduce investigations and challenge specific aspects of its economic agenda.</p><p><strong>However, a change in Congressional control should not automatically be interpreted as an end to tariffs.</strong></p><p>The US President retains substantial executive authority over trade policy. Congressional opposition can create political and legislative constraints, but reversing existing tariff measures is considerably more complicated.</p><p>This distinction is particularly important for Asian economies.</p><p>China remains directly exposed to US trade restrictions, while Vietnam, Taiwan, South Korea, Japan and India are navigating a more complicated environment of supply-chain diversification, export competitiveness and market access.</p><p><strong>For India, the opportunity and risk are particularly interesting.</strong></p><p>The global reconfiguration of manufacturing supply chains could continue to create opportunities in electronics, pharmaceuticals, industrial manufacturing and technology services.</p><p>However, the benefits depend on India’s ability to remain commercially competitive while navigating changing US trade arrangements.</p><p>For other Asian exporters, the challenge is equally significant. Companies may need to absorb additional compliance costs, reconsider manufacturing locations or diversify their customer base.</p><p><strong>The larger implication is that trade uncertainty is unlikely to disappear simply because Congressional control changes.</strong></p><p>Instead, markets may have to price a more complicated environment in which the administration retains considerable trade-policy authority while facing greater political resistance.</p><p><strong>4. The global market transmission: America, Europe and Asia</strong></p><p>The most important aspect of this election is how quickly political developments in the US translate into changes in global capital allocation.</p><p><strong>America: Technology and fiscal uncertainty</strong></p><p>The immediate pressure on US markets reflects concerns about AI regulation, technology-sector oversight and a potentially more complicated fiscal environment.</p><p>A Democratic Congress could constrain parts of the administration’s legislative agenda and increase scrutiny of corporate activity.</p><p>At the same time, lower expectations for additional fiscal stimulus could influence growth forecasts and the outlook for Treasury issuance.</p><p><strong>The initial decline in Treasury yields and the softer dollar suggest investors are reassessing both growth expectations and the political risk premium</strong>.</p><p>However, lower yields could eventually provide some support to equity valuations, particularly if the market interprets the outcome as reducing deficit-financed expansion.</p><p><strong>Asia: Semiconductor exposure and currency sensitivity</strong></p><p>Asia is likely to experience the effects through two principal channels.</p><p>The first is technology-sector exposure. Any reassessment of American AI infrastructure spending directly affects semiconductor manufacturers and equipment suppliers across the region.</p><p><strong>The second is currency and capital flows</strong>.</p><p>A softer dollar can provide some relief to Asian currencies and reduce certain imported cost pressures. It may also improve the relative attractiveness of emerging-market assets, although this will depend on global risk appetite and domestic economic fundamentals.</p><p>India provides an interesting example. Reuters reported on November 4 that the rupee had strengthened to a near two-week high as dollar weakness and improving flows supported its recovery.</p><p>This is a reminder that political developments in Washington can influence emerging-market currencies even when the underlying economic fundamentals have not changed overnight.</p><p><strong>Europe: Trade exposure and technology spillovers</strong></p><p>European markets face a somewhat different set of considerations.</p><p>European exporters remain exposed to US trade policy, particularly in industrial goods, automotive manufacturing and selected consumer sectors.</p><p>Meanwhile, European technology and semiconductor-equipment companies are linked to the same global investment cycle underpinning American AI expansion.</p><p><strong>A reassessment of US technology spending could therefore affect European companies even without any direct change in European policy</strong>.</p><p>Currency movements add another layer<strong>. A weaker dollar can support the euro, but it can also complicate the earnings translation of European companies with substantial US revenues</strong>.</p><p>The broader question for Europe is whether a more constrained American policy environment creates greater stability in international trade or simply prolongs uncertainty.</p><p><strong>5. The overlooked issue: Congressional gridlock and fiscal policy</strong></p><p>Perhaps the most underappreciated implication of the election is the possibility of political gridlock.</p><p>The US administration retains executive authority, including significant influence over trade, foreign policy and regulation. However, a Congress controlled by the opposing party can make major legislative initiatives considerably more difficult.</p><p>This creates uncertainty around several important areas:</p><p>Debt-ceiling negotiations and government funding<br> Tax policy and corporate incentives<br> Healthcare subsidies and government expenditure<br> Energy transition and infrastructure spending<br> Congressional investigations and regulatory oversight</p><p><strong>The debt ceiling is particularly important because the next major negotiations could become a source of market volatility in 2027.</strong></p><p>Reuters’ pre-election investor analysis highlighted the possibility that a change in Congressional control <strong>could increase the risk of fiscal negotiations </strong>and complicate the outlook for government funding.</p><p>For bond markets, this matters because the US fiscal position is already a significant consideration in determining long-term Treasury yields and investor confidence.</p><p>For equity markets, the implications are less straightforward.</p><p>Political gridlock can sometimes limit the introduction of disruptive legislation, but it can also delay policy decisions and create uncertainty around government spending.</p><p>The result is not necessarily a uniformly negative environment for markets. It is an environment in which investors may have to become more selective about the policy assumptions underpinning their valuations.</p><p><strong>What should investors watch over the next 24 months?</strong></p><p>The immediate market reaction is important, but the more consequential signals will emerge through actual policy developments and corporate decisions.</p><p>I would focus on five indicators:</p><p><strong>Hyperscaler capital expenditure:</strong> Whether Microsoft, Amazon, Alphabet and Meta maintain their AI infrastructure spending commitments.<br><strong>AI regulation and data-centre approvals:</strong> Whether Congressional investigations and state-level restrictions translate into tangible constraints on infrastructure expansion.<br><strong>Healthcare legislation:</strong> Whether drug pricing, insurance affordability and Medicare/Medicaid funding become central legislative priorities.<br><strong>Trade policy:</strong> Whether Congressional oversight produces meaningful changes to tariff implementation or simply adds another layer of uncertainty.<br><strong>US fiscal negotiations:</strong> Whether debt-ceiling and government funding discussions begin to influence Treasury yields, the dollar and broader risk sentiment.</p><p>These indicators will provide a much better understanding of the economic consequences than the initial election-day market reaction.</p><p><strong>The bigger picture</strong></p><p>The 2026 US Midterms reinforce an increasingly important reality about global investing: markets are no longer responding only to interest rates, inflation and corporate earnings. They are also responding to the intersection of geopolitics, regulation and government policy.</p><p>AI investment in the US influences semiconductor revenues in Asia. American healthcare policy affects pharmaceutical economics globally. Tariff decisions reshape manufacturing strategies across emerging markets. And Washington’s fiscal outlook influences currencies, bond markets and international capital flows.</p><p><strong>The initial market reaction may be volatile, but it would be premature to interpret the election as an automatic reversal of the administration’s economic agenda</strong>. Executive authority remains significant, and the ability to translate political opposition into actual policy changes is far from guaranteed.</p><p>What may change more immediately is the level of uncertainty surrounding the next phase of corporate investment and global trade.</p><p><strong>The next phase of the market may be less about who is investing in the future, and more about who gets to shape the rules under which that investment happens.</strong></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ff3bd7be5696" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>